Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effects of Spironolactone Against Anthracycline Induced Cardiomyopathy

NCT02053974 is registered in ClinicalTrials.gov with TC Erciyes University as lead sponsor.

NCT NCT02053974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02053974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effects of Spironolactone Against Anthracycline Induced Cardiomyopathy
Lead sponsor
TC Erciyes University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
October 31, 2012
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anthracycline induced cardiotoxicity